Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Lung Cancer

Free Subscription 26.01.2026 1 Am J Pathol 1 Ann Oncol 1 Ann Surg Oncol 1 Ann Thorac Surg 5 BMC Cancer 1 Cancer Lett 1 Cancer Sci 1 Clin Lung Cancer 4 Eur J Cancer 3 Eur J Cardiothorac Surg 1 Int J Radiat Oncol Biol Phys 7 J Clin Oncol 1 J Comput Assist Tomogr 1 J Natl Cancer Inst 6 Lung Cancer 1 Nat Med 1 Oncogene 1 Oncol Rep 3 PLoS One 1 Thorax

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Pathol

1. NANAYAKKARA J, Yang X, Damiani S, Imtiaz T, et al
   YAP and TEAD Are Transcriptional Regulators of Neuroendocrine Differentiation and Growth in Carcinoid Cells.
   Am J Pathol. 2026;196:345-358.
   PubMed         Abstract available
   
   

   
   Ann Oncol

2. SANTUCCI C, Mignozzi S, Levi F, Malvezzi M, et al
   European cancer mortality predictions for the year 2026: the levelling of female lung cancer mortality.
   Ann Oncol. 2026 Jan 19:S0923-7534(25)06319-7. doi: 10.1016/j.annonc.2025.
   PubMed         Abstract available
   
   

   
   Ann Surg Oncol

3. CHEN Q, Yao M, Chen Z, Liu S, et al
   N-LODDS: A Novel Integrated Lymph Node Staging System Enhancing Prognostic Accuracy in Non-Small-Cell Lung Cancer.
   Ann Surg Oncol. 2026 Jan 20. doi: 10.1245/s10434-025-19005.
   PubMed         Abstract available
   
   

   
   Ann Thorac Surg

4. TUPPER HI, Shrager JB, Moghanaki D, Simone CB 2nd, et al
   Misinformation and Overestimation of Computed Tomography Lung Cancer Screening Harms - Methodology Matters: A Joint Statement from the Society of Thoracic Surgeons, the American Society for Radiation Oncology, and the American College of Radiology.
   Ann Thorac Surg. 2027 Nov 11:S0003-4975(25)01112.
   PubMed        
   
   

   
   BMC Cancer

5. SUN S, Zhang R, Tan S, Zhang Y, et al
   Association between ALK tyrosine kinase inhibitor and the risk of interstitial lung disease and pneumonitis in non-small cell lung cancer patients: a systematic review.
   BMC Cancer. 2026 Jan 24. doi: 10.1186/s12885-026-15612.
   PubMed        
   
   
6. ZHANG W, Wu X, Sun X, Wen J, et al
   Dynamic liver dysfunction predicts poor survival in patients with EGFR-mutant non-small cell lung cancer and liver metastases treated with EGFR tyrosine kinase inhibitors.
   BMC Cancer. 2026 Jan 23. doi: 10.1186/s12885-026-15616.
   PubMed        
   
   
7. LI F, Zhang C, Huang L, Wang Z, et al
   Neoadjuvant immunochemotherapy vs. neoadjuvant targeted therapy plus chemotherapy for EGFR-mutated non-small cell lung cancer: a retrospective study.
   BMC Cancer. 2026 Jan 20. doi: 10.1186/s12885-026-15582.
   PubMed        
   
   
8. FENG Y, Qiao Y, Li H, Shen B, et al
   Investigating the causal link between metformin and lung cancer risk: a two-sample mendelian randomization analysis.
   BMC Cancer. 2026 Jan 19. doi: 10.1186/s12885-025-15494.
   PubMed        
   
   
9. XIAO J, Zhu Z, Zhang F, Wang X, et al
   The potential of MMP14 as a prognostic and immune biomarker in lung cancer.
   BMC Cancer. 2026 Jan 17. doi: 10.1186/s12885-025-15539.
   PubMed        
   
   

   
   Cancer Lett

10. DONG X, Li R, Yao X, Li Y, et al
    Strategies to optimize duration of immunotherapy in advanced NSCLC: Current evidence and future directions.
    Cancer Lett. 2026;639:218203.
    PubMed         Abstract available
    
    

    
    Cancer Sci

11. NAM SY, Jo J, Choi SH
    Effect Modification by Cofactors in the Impact of Body Mass Index Change on the Risk of Lung Cancer.
    Cancer Sci. 2026 Jan 23. doi: 10.1111/cas.70332.
    PubMed         Abstract available
    
    

    
    Clin Lung Cancer

12. POUDEL R, Bowles KE, Islam JY, Altinok O, et al
    Computed Tomography-Based Radiomics Features Characterize Low and High-Risk Lung Cancer Among People Living With HIV: An Early Report.
    Clin Lung Cancer. 2025;27:69-74.
    PubMed        
    
    

    
    Eur J Cancer

13. AMMONI LC, Cortesi V, Borghetti P, Baggi A, et al
    Ambient air pollution and survival in SCLC/LCNEC: Analysis of a single centre retrospective cohort.
    Eur J Cancer. 2026;234:116190.
    PubMed         Abstract available
    
    
14. GUO W, Zhao L, Chen X, Wang S, et al
    Phase II trial of neoadjuvant camrelizumab and apatinib in resectable NSCLC: 3-year survival outcomes and dynamic circulating tumor DNA analyses.
    Eur J Cancer. 2026;234:116198.
    PubMed         Abstract available
    
    
15. BUDOLFSEN T, Petersen RH, Moller LB, Brabrand J, et al
    Why are patients with non-small cell lung cancer in stage I-IIIA considered inoperable? A registry-based study from the capital region of Denmark.
    Eur J Cancer. 2026;235:116246.
    PubMed         Abstract available
    
    
16. ADDEO A, Fruh M
    Corrigendum to "Thoracic radiotherapy plus maintenance durvalumab after first line carboplatin and etoposide plus durvalumab in extensive-stage disease small cell lung cancer (ES-SCLC) - A multicenter single arm open label phase II trial (SAKK 15/19)"
    Eur J Cancer. 2026;235:116224.
    PubMed        
    
    

    
    Eur J Cardiothorac Surg

17. PRISCIANDARO E, Bertolaccini L, Fieuws S, Ceulemans LJ, et al
    Predictors of Loco-Regional Recurrence After Pulmonary Non-Anatomical Metastasectomy: A Multicentre Retrospective Analysis.
    Eur J Cardiothorac Surg. 2026;68:ezag003.
    PubMed         Abstract available
    
    
18. HU Y, Xiao R, Li Z, He W, et al
    Development of a Comprehensive Model Combining Clinical, Radiomics With Deep Learning for Predicting the Micropapillary Pattern in
    Eur J Cardiothorac Surg. 2026;68:ezag002.
    PubMed         Abstract available
    
    
19. JONES DG, Anstee C, Yasufuku K, Malthaner R, et al
    Financial Burden of Postoperative Adverse Events Following Lobectomy: Cost Analysis From 10 High-Volume Canadian Hospitals.
    Eur J Cardiothorac Surg. 2026;68:ezag008.
    PubMed         Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

20. TUPPER HI, Shrager JB, Moghanaki D, Simone CB 2nd, et al
    Misinformation and Overestimation of Computed Tomography Lung Cancer Screening Harms-Methodology Matters: A Joint Statement from The Society of Thoracic Surgeons, the American Society for Radiation Oncology, and the American College of Radiology.
    Int J Radiat Oncol Biol Phys. 2027 Nov 11:S0360-3016(25)06618.
    PubMed        
    
    

    
    J Clin Oncol

21. WERMKE M, Gambardella V, Kuboki Y, Felip E, et al
    Reply to: Delta-Like Ligand 3 Expression Across Lung Neuroendocrine Subtypes: Interpreting Response in Small Cell Lung Cancer and Beyond.
    J Clin Oncol. 2026 Jan 22:JCO2502654. doi: 10.1200/JCO-25-02654.
    PubMed        
    
    
22. CHEN Y, Liu L, Ming Y, Chen L, et al
    Delta-Like Ligand 3 Expression Across Lung Neuroendocrine Subtypes: Interpreting Response in Small Cell Lung Cancer and Beyond.
    J Clin Oncol. 2026 Jan 22:JCO2501894. doi: 10.1200/JCO-25-01894.
    PubMed        
    
    
23. REMON J, Cascone T, Peters S
    BR.31 Trial: Adjuvant Durvalumab as the Third Contender in Resected Non-Small Cell Lung Cancer.
    J Clin Oncol. 2026 Jan 22:JCO2502696. doi: 10.1200/JCO-25-02696.
    PubMed        
    
    
24. RUSTHOVEN CG, Serizawa T, Yamamoto M
    Radiosurgery for Small Cell Lung Cancer Brain Metastases: Comparing the JLGK0901 and BWH/DFCI Trials.
    J Clin Oncol. 2026 Jan 20:JCO2501794. doi: 10.1200/JCO-25-01794.
    PubMed        
    
    
25. NOGUCHI M, Nimura K, Koide Y
    Expanding Indications for Stereotactic Radiosurgery in Small Cell Lung Cancer With Brain Metastases.
    J Clin Oncol. 2026 Jan 20:JCO2501867. doi: 10.1200/JCO-25-01867.
    PubMed        
    
    
26. AKDOGAN O, Canaslan K, Hamitoglu B, Yazici O, et al
    Limitations in Study Design and Stratification in Phase II Stereotactic Radiosurgery Trial for Small Cell Lung Cancer Brain Metastases.
    J Clin Oncol. 2026 Jan 20:JCO2501729. doi: 10.1200/JCO-25-01729.
    PubMed        
    
    
27. AIZER AA, Catalano PJ, Rahman R
    Reply to: "Limitations in Study Design and Stratification in Phase II Stereotactic Radiosurgery Trial for Small Cell Lung Cancer Brain Metastases," "Radiosurgery for Small Cell Lung Cancer Brain Metastases: Comparing the JLGK0901 and BWH/DFCI Trials,"
    J Clin Oncol. 2026 Jan 20:JCO2502528. doi: 10.1200/JCO-25-02528.
    PubMed        
    
    

    
    J Comput Assist Tomogr

28. TESSA C, Picozzi G, Cozzi D, Cavigli E, et al
    Underreporting of Coronary Stents in LDCT for Lung Cancer Screening and Their Differentiation From Severe Coronary Artery Calcifications.
    J Comput Assist Tomogr. 2025 Dec 5. doi: 10.1097/RCT.0000000000001826.
    PubMed         Abstract available
    
    

    
    J Natl Cancer Inst

29. CAO P, De Nijs K, Lee J, Jeon J, et al
    Performance of smoking duration-based lung cancer screening eligibility criteria: a comparative modeling study.
    J Natl Cancer Inst. 2026 Jan 23:djag018. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Lung Cancer

30. BARSOUK A, Heidlauf A, Goel K, Rushkin L, et al
    Osimertinib dose-reduction and survival in 1L EGFR-mutated metastatic non-small cell lung cancer (mNSCLC).
    Lung Cancer. 2026;213:108936.
    PubMed         Abstract available
    
    
31. SEYYEDSALEHI MS, Cani M, Wang Q, Thakur C, et al
    Lung cancer in women: current evidence and future research priorities.
    Lung Cancer. 2026;213:108905.
    PubMed         Abstract available
    
    
32. MURASE Y, Koba H, Kimura H, Matsumoto I, et al
    Prognostic value of preoperative ctDNA and pathological venous invasion for recurrence in EGFR-mutated non-small cell lung cancer.
    Lung Cancer. 2025;213:108818.
    PubMed         Abstract available
    
    
33. HAYASAKA K, Shimokawa M, Haratake N, Notsuda H, et al
    Survival outcomes of patients with uncommon EGFR mutations in surgically resected lung adenocarcinoma: A multi-institutional real-world database study (CReGYT-01 EGFR study).
    Lung Cancer. 2026;212:108908.
    PubMed         Abstract available
    
    
34. ZWIJSEN K, Heirwegh E, Schillebeeckx E, Marcq E, et al
    Multi-omic screening for pleural mesothelioma in Asbestos-Exposed Populations: A literature review and Recommendations.
    Lung Cancer. 2026;212:108893.
    PubMed         Abstract available
    
    
35. CUNNIFFE C, Sperrin M, Walls G, Blackhall F, et al
    External evaluation of the Manchester score in a contemporary SCLC cohort.
    Lung Cancer. 2026;212:108884.
    PubMed         Abstract available
    
    

    
    Nat Med

36. ZHAO H, Bai Y, Chen L, Ma J, et al
    Generative AI-based low-dose digital subtraction angiography for intra-operative radiation dose reduction: a randomized controlled trial.
    Nat Med. 2026;32:288-296.
    PubMed         Abstract available
    
    

    
    Oncogene

37. LI H, Wu J, Dai H, Li J, et al
    PDZRN4 suppresses lung adenocarcinoma progression via inhibiting ubiquitin-mediated HIF-1A degradation.
    Oncogene. 2026;45:577-590.
    PubMed         Abstract available
    
    

    
    Oncol Rep

38. JIANG J, Dong G, Zhang Z, Lei X, et al
    Recapitulating lung cancer metastasis in vitro: Advances in organoid models and challenges in clinical translation (Review).
    Oncol Rep. 2026;55:49.
    PubMed         Abstract available
    
    

    
    PLoS One

39. PAN Y, Ding X, Duan W, Wang L, et al
    A screening strategy based on machine learning for diagnostic biomarkers in small cell lung cancer.
    PLoS One. 2026;21:e0339195.
    PubMed         Abstract available
    
    
40. WANG J, Lin L, Qiu LP, Zheng LL, et al
    Assessing in-hospital mortality risk in ICU lung cancer patients using machine learning: An analysis based on the MIMIC-IV database.
    PLoS One. 2026;21:e0341259.
    PubMed         Abstract available
    
    
41. BOROWSKA M, Mojsak M, Bebas E, Pauk J, et al
    Machine learning using entropy-based texture features from MRI to differentiate histological subtypes of non-small cell lung cancer identified as metabolically active on PET/MRI.
    PLoS One. 2026;21:e0338373.
    PubMed         Abstract available
    
    

    
    Thorax

42. KIJLERTSUPHASRI S, Petnak T, Moua T
    Antifibrotic therapy and lung cancer risk in patients with idiopathic pulmonary fibrosis: a large retrospective propensity-weighted cohort study.
    Thorax. 2026 Jan 21:thorax-2025-223803. doi: 10.1136/thorax-2025-223803.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge.